Clinical

Dataset Information

0

Metastatic Colorectal Cancer Liver Metastases Outcomes After Resin 90Y Microsphere Radioembolization in the USA Evaluation Project

ABSTRACT: Investigator initiated multi-institutional retrospective review of clinical and radiographic outcomes after 90Y resin microsphere radioembolization for metastatic colorectal liver metastases in the USA. The target is for at least 1,000 evaluable patients with 12+ weeks follow up.

DISEASE(S): Neoplasm Metastasis,Liver Metastases,Colorectal Cancer,Colorectal Neoplasms,Liver Neoplasms

PROVIDER: 2141926 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Json Xml

Similar Datasets

Unknown Transarterial Radioembolization (TARE) Agents beyond 90Y-Microspheres.
| S-EPMC6330886 | biostudies-other
Unknown 90Y Resin Microspheres Radioembolization for Colon Cancer Liver Metastases Using Full-Strength Contrast Material.
| S-EPMC6853060 | biostudies-literature
Unknown Contralateral Liver Hypertrophy and Oncological Outcome Following Radioembolization with 90Y-Microspheres: A Systematic Review.
| S-EPMC7072354 | biostudies-literature
Unknown The Predictive Value of SPECT/CT imaging in colorectal liver metastases response after 90Y-radioembolization.
| S-EPMC6039046 | biostudies-literature
Unknown Inter-observer variability of 90Y PET/CT dosimetry in hepatocellular carcinoma after glass microspheres transarterial radioembolization.
| S-EPMC7218042 | biostudies-literature
Unknown Hepatopulmonary Shunting: A Prognostic Indicator of Survival in Patients with Metastatic Colorectal Adenocarcinoma Treated with 90Y Radioembolization.
| S-EPMC5207118 | biostudies-literature
Clinical Safety Study of 90Y-hMN14 to Treat Colorectal Cancer
| 2007868 | ecrin-mdr-crc
Clinical Biopsy After Radioembolization to Identify Changes in Tumor Cells From the Radiation
| 2360780 | ecrin-mdr-crc
Clinical SWARM_Systemic release of growth factors after radioembolization of hepatic malignancies
| 2721073 | ecrin-mdr-crc
Clinical Safety Study of 90Y-hMN14 to Treat Colorectal Cancer Patients With Limited Residual Disease After Surgery
| 2007940 | ecrin-mdr-crc